What is a stock summary page? Click here for an overview.
Business Description
AB Science
NAICS : 325411
ISIN : FR0010557264
Compare
Compare
Traded in other countries / regions
AB.FranceA8D.Germany0Q77.UKABSCF.USA IPO Date
2011-01-05Description
AB Science is a France-based pharmaceutical company specialized in the research, discovery, development, and marketing of protein kinase inhibitors. It is engaged in targeted therapies through tyrosine kinase inhibitors for treating diseases with high medical factor in the field of cancer, chronic inflammatory diseases, neurological degenerative disorders and central nervous systems diseases in both human and veterinary medicine.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.48 | |||||
| Equity-to-Asset | -1.07 | |||||
| Debt-to-Equity | -0.77 | |||||
| Debt-to-EBITDA | -21.46 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 0.18 | |||||
| Beneish M-Score | -0.02 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -27 | |||||
| 3-Year EBITDA Growth Rate | 37.2 | |||||
| 3-Year EPS without NRI Growth Rate | 15.8 | |||||
| 3-Year FCF Growth Rate | 7.1 | |||||
| 3-Year Book Growth Rate | 1.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | -19.78 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 11.08 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 99.99 | |||||
| 9-Day RSI | 99.6 | |||||
| 14-Day RSI | 98.09 | |||||
| 3-1 Month Momentum % | 74.44 | |||||
| 6-1 Month Momentum % | 48.11 | |||||
| 12-1 Month Momentum % | -41.85 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.82 | |||||
| Quick Ratio | 0.8 | |||||
| Cash Ratio | 0.52 | |||||
| Days Inventory | 535.43 | |||||
| Days Sales Outstanding | 61.4 | |||||
| Days Payable | 9544.44 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.6 | |||||
| Shareholder Yield % | 2.32 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 76.25 | |||||
| Operating Margin % | -754.25 | |||||
| Net Margin % | -379.48 | |||||
| FCF Margin % | -421.93 | |||||
| ROA % | -15.08 | |||||
| ROIC % | -46.02 | |||||
| 3-Year ROIIC % | 24.42 | |||||
| ROC (Joel Greenblatt) % | -222.09 | |||||
| ROCE % | -25.44 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 76.47 | |||||
| EV-to-EBIT | -45.96 | |||||
| EV-to-EBITDA | -106.12 | |||||
| EV-to-Revenue | 86.7 | |||||
| EV-to-FCF | -20.88 | |||||
| Price-to-GF-Value | 0.23 | |||||
| Price-to-Median-PS-Value | 0.43 | |||||
| Earnings Yield (Greenblatt) % | -2.18 | |||||
| FCF Yield % | -5.35 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ABSCF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
AB Science Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.172 | ||
| EPS (TTM) ($) | -0.089 | ||
| Beta | -0.16 | ||
| 3-Year Sharpe Ratio | -0.58 | ||
| 3-Year Sortino Ratio | -0.75 | ||
| Volatility % | 101.07 | ||
| 14-Day RSI | 98.09 | ||
| 14-Day ATR ($) | 0.002755 | ||
| 20-Day SMA ($) | 1.57 | ||
| 12-1 Month Momentum % | -41.85 | ||
| 52-Week Range ($) | 0.8 - 2.7 | ||
| Shares Outstanding (Mil) | 64.59 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
AB Science Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
AB Science Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
AB Science Frequently Asked Questions
What is AB Science(ABSCF)'s stock price today?
The current price of ABSCF is $1.57. The 52 week high of ABSCF is $2.70 and 52 week low is $0.80.
When is next earnings date of AB Science(ABSCF)?
The next earnings date of AB Science(ABSCF) is 2025-10-07 Est..
Does AB Science(ABSCF) pay dividends? If so, how much?
AB Science(ABSCF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers